Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03412565 |
Title | A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies |
Bortezomib + Daratumumab + Dexamethasone + Melphalan + Prednisone |
Age Groups: | senior | adult |
Covered Countries | USA | FRA | ESP | DEU |